Alpha Tau Medical Income Statement (2020-2026) | DRTS

1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Shares Outstanding (Entity) (Quarter)
44.75M44.78M52.47M64.09M76.00M70.18M76.45M33.75M76.57M76.64M77.01M36.97M77.17M77.24M77.82M40.77M86.96M89.01M99.09M99.78M
Operating items
Research & Development (Quarter)
3.03M3.23M5.24M5.45M4.83M5.38M6.31M5.96M6.67M7.49M6.45M6.87M6.17M7.53M7.17M7.01M8.31M9.58M10.97M9.91M
Selling, General & Administrative (Quarter)
0.50M0.59M3.34M2.44M2.28M2.21M1.94M1.69M1.70M2.00M1.44M1.59M1.59M2.05M1.68M2.18M1.93M2.57M2.10M3.56M
Operating Expenses (Quarter)
3.53M3.82M8.57M7.89M7.11M7.59M8.24M7.65M8.37M9.49M7.89M8.45M7.76M9.59M8.85M9.19M10.24M12.15M13.07M13.47M
Operating Income (Quarter)
3.63M3.94M8.78M8.01M7.36M7.99M8.64M8.17M8.93M9.94M8.42M9.05M8.29M10.27M9.31M9.65M10.73M12.60M13.31M-40.41M
EBIT (Quarter)
3.63M3.94M8.78M8.01M7.36M7.99M8.64M8.17M8.93M9.94M8.42M9.05M8.29M10.27M9.31M9.65M10.73M12.60M13.31M-40.41M
Non-operating items
Interest & Investment Income (Quarter)
1.17M-0.15M16.96M-6.02M-4.74M-4.59M-0.48M0.46M-0.72M9.64M
Other Non Operating Income (Quarter)
-6.11M10.82M-6.25M8.14M
Non Operating Income (Quarter)
16.96M-6.02M-4.74M-4.59M-0.48M0.50M-3.97M10.49M-0.44M-1.69M-1.37M7.80M-0.72M0.40M0.96M-0.87M
Net income details
EBT (Quarter)
4.80M3.79M25.74M1.99M2.61M3.39M8.17M8.67M4.95M7.36M7.98M7.37M6.92M9.47M8.59M10.05M11.69M12.17M22.95M-91.48M
Tax Provisions (Quarter)
-0.01M-0.01M0.00M0.01M0.01M0.00M0.02M0.03M-0.04M0.01M0.00M0.00M0.00M0.10M0.07M-0.01M-0.04M
Profit After Tax (Quarter)
4.80M3.78M25.74M2.00M2.62M3.40M8.19M8.69M4.91M7.37M7.98M7.37M6.92M9.48M8.69M10.11M11.69M12.14M22.94M-91.69M
Income from Continuing Operations (Quarter)
4.81M3.81M25.74M1.99M2.60M3.39M8.14M8.64M4.99M7.35M7.98M7.36M6.92M9.47M8.49M9.98M11.70M12.21M22.95M-91.48M
Income from Discontinued Operations (Quarter)
0.10M-0.01M
Consolidated Net Income (Quarter)
4.81M3.81M25.74M1.99M2.60M3.39M8.14M8.64M4.99M7.35M7.98M7.36M6.92M9.47M8.59M9.98M11.70M12.21M22.94M-91.48M
Income towards Parent Company (Quarter)
4.81M3.81M25.74M1.99M2.60M3.39M8.14M8.64M4.99M7.35M7.98M7.36M6.92M9.47M8.59M9.98M11.70M12.21M22.94M-91.48M
Net Income towards Common Stockholders (Quarter)
4.81M3.81M25.74M1.99M2.60M3.39M8.14M8.64M4.99M7.35M7.98M7.36M6.92M9.47M8.59M9.98M11.70M12.21M22.94M-91.48M
Additional items
EPS (Basic) (Quarter)
0.120.090.540.030.040.050.120.280.070.110.110.220.100.140.120.270.150.150.26-1.01
EPS (Diluted) (Quarter)
0.120.090.640.030.040.050.130.120.070.110.120.110.100.140.120.130.160.150.28-1.01
Shares Outstanding (Quarter)
40.52M40.53M47.50M58.02M68.80M63.53M69.21M30.56M69.31M69.38M69.71M33.47M69.86M69.93M70.45M36.91M78.72M80.58M89.71M90.33M
Shares Outstanding (Diluted) (Quarter)
40.27M40.53M40.53M58.02M58.02M63.53M63.53M69.26M69.26M69.38M69.38M69.79M69.79M69.93M69.93M75.45M75.45M80.58M80.58M90.33M
EBITDA (Quarter)
3.63M3.94M8.78M8.01M7.36M7.99M8.64M8.17M8.93M9.94M8.42M9.05M8.29M10.27M9.31M9.65M10.73M12.60M13.31M-40.41M
Interest Expenses (Quarter)
3.80M0.04M0.01M5.08M5.56M5.84M9.86M7.13M9.76M22.63M133.76M
Tax Rate (Quarter)
-0.10-0.370.010.300.340.090.260.30-0.790.110.010.040.021.150.65-0.07-0.29